Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice.
Reads0
Chats0
TLDR
The pattern of mouse hepatitis virus (MHV) JHM dissemination in blood and other tissues was examined during the first 5 days following intranasal inoculation and suggested lymphatic spread of virus to cervical lymph node and mesenteric lymph node as pathways of dissemination in addition to viremia.Abstract:
Using a sensitive infant mouse bioassay to detect infectious virus, the pattern of mouse hepatitis virus (MHV) JHM dissemination in blood and other tissues was examined during the first 5 days following intranasal inoculation. MHV replicated in nasal turbinates of both susceptible BALB and resistant SJL mice from days 1 through 5, but BALB mice had higher titers on days 1 and 2. Viremia was detectable on days 1 through 5 in BALB mice, but only on days 3 and 5 in SJL mice. Transient virus replication occurred in the lungs of both mouse genotypes at 1 and 2 days, then ceased. This correlated with more consistently demonstrable virus in blood collected from the left atrium of the heart, compared to jugular vein, portal vein and right atrial blood. Virus was associated equally with the plasma and cellular fractions of blood on day 3, but was primarily in the buffy coat of the cellular fraction on day 5. Interferon-α/β was detected in serum and spleen, but not liver or brain of BALB mice or in any tissue of SJL mice. BALB serum and spleen interferon was first detected at 36h, peaked between 48 and 72h, and was undetectable by 108h. The distribution of virus in nose, cervical, axillary and mesenteric lymph nodes, spleen, Peyer's patch, thymus, bone marrow and liver was examined at 1, 2, and 3 days. The resulting pattern suggested lymphatic spread of virus to cervical lymph node and mesenteric lymph node as pathways of dissemination in addition to viremia.read more
Citations
More filters
Journal ArticleDOI
Detection of Severe Acute Respiratory Syndrome Coronavirus in the Brain: Potential Role of the Chemokine Mig in Pathogenesis
Jun Xu,Shuqing Zhong,Jinghua Liu,Li Li,Yong Li,Xinwei Wu,Zhi-jie Li,Peng Deng,Jingqiang Zhang,Nanshan Zhong,Yanqing Ding,Yong Jiang +11 more
TL;DR: Direct evidence is provided that SARS human coronavirus is capable of infecting the central nervous system, and that Mig might be involved in the brain immunopathology of SARS.
Journal ArticleDOI
Neuroinvasion by Human Respiratory Coronaviruses
TL;DR: The presence of HCoV in human brains is consistent with neuroinvasion by these respiratory pathogens, and the presence of viral RNA in brain parenchyma, outside blood vessels is confirmed.
Journal ArticleDOI
Natural Pathogens of Laboratory Mice, Rats, and Rabbits and Their Effects on Research
TL;DR: Investigators using mice, rats, and rabbits in biomedical experimentation should be aware of the profound effects that many of the natural pathogens of these laboratory animals may alter host physiology, rendering the host unsuitable for many experimental uses.
Journal ArticleDOI
Acute and Persistent Infection of Human Neural Cell Lines by Human Coronavirus OC43
Nathalie Arbour,Geneviève Côté,Claude Lachance,Marc Tardieu,Neil R. Cashman,Pierre J. Talbot +5 more
TL;DR: Bonavia et al. as mentioned in this paper showed that the neurotropism of HuCV will lead to persistence within the central nervous system, as was observed for murine coronaviruses.
Journal ArticleDOI
Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo.
TL;DR: Induction of major histocompatibility complex class I (MHC-I) molecules on cells in infected brains was demonstrated by immunohistochemical analyses in normal and nude mice, suggesting that IFN-gamma may not be necessary for induction of MHC- I on neural cells in vivo.
References
More filters
Journal ArticleDOI
Convenient assay for interferons.
TL;DR: A convenient assay for interferons based on reduction of cytopathic effect was developed and can be used with various types of cells and a variety of viruses.
Book ChapterDOI
The Biology and Pathogenesis of Coronaviruses
TL;DR: The coronavirases were first recognized and morphologically defined as a group by Tyrrell and co-workers (1968, 1975, 1978) and biochemical studies have recently provided additional information which allows better characterization of these agents.
Journal ArticleDOI
Genetic resistance to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues.
TL;DR: SJL/J mice may be resistant to mouse hepatitis virus A59 infection because they lack a specific virus receptor which is present on the plasma membranes of target cells from genetically susceptible BALB/c and semisusceptible C3H mice.
Journal ArticleDOI
Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice.
TL;DR: SJL/J mice express a protein which shares some sequence homology with the MHV receptor but which lacks virus-binding activity and is not recognized by the blocking anti-receptor MAb, suggesting resistance of SJL/j mice to MHV-A59 may be due to absence or mutation of the virus- binding domain in the nonfunctional receptor homolog in SJL-susceptible mice.
Journal Article
Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms.
TL;DR: In this paper, Humoral and cell-mediated immune responses were studied in resistant and susceptible strains of mice infected with mouse hepatitis virus type III (MHV 3) by regular passages in susceptible DBA/2 mice and assayed by LD-50 determination.